drugset / Trial / NCT02633579

Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways

NCT02633579

Completed 28 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedCrossoverSingle-blind

Summary

In this study, the investigators will evaluate if the food intake associated with the infusion of erythromycin is caused by the phase 3 contractions or by another yet unknown effect of erythromycin. To obtain this the investigators will use atropine, a muscarinic receptor antagonist, to inhibit the formation of contractions induced by a low dose of erythromycin

Timeline

Start
2012-10
Primary completion
2014-08
Completion
2014-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 15 ug/kg Intravenous
Comparator Erythromycin Small molecule 40 mg Intravenous

Indications

No indication recorded.